Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lechler

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Zeitschrift Fur Hautkrankheiten|December 1, 1986
[Hemophilia and HTLV-III infection]E Lechler
Haemostasis|January 1, 1996
The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study GroupE Lechler, W Schramm, C W Flosbach
Klinische Wochenschrift|May 3, 1991
High rate of false positives in blood donor screening for antibodies to hepatitis C virus. Cause of underestimation of virus transmission rate?W Prohaska, C Wolff, E Lechler, et al.
Thrombosis and Haemostasis|October 6, 1998
Thromboembolic complications associated with the use of prothrombin complex and factor IX concentratesM Köhler, P Hellstern, E Lechler, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 1, 1988
[Treatment of arterial occlusions of the lower extremities using 2-stage local application of urokinase]W Gross-Fengels, K F Neufang, E Lechler, et al.
Thrombosis and Haemostasis|October 1, 1996
Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1R Schneppenheim, U Budde, S Krey, et al.
Cancer Research|September 1, 1985
Prevalence of antibodies to HTLV-III in AIDS risk groups in West GermanyV Erfle, R Hehlmann, W Mellert, et al.
Blut|October 1, 1985
Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood productsV Erfle, R Hehlmann, W Mellert, et al.
Vox Sanguinis|January 1, 1988
Plasminogen hemizygosity. Detection of a silent allele in 7 members of a family by determination of plasminogen phenotypes, antigenic levels, and functional activityU Skoda, S F Goldmann, C Händler, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V LeidenI Pabinger, L Nemes, C Rintelen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Zeitschrift Fur Hautkrankheiten|December 1, 1986
[Hemophilia and HTLV-III infection]E Lechler
Haemostasis|January 1, 1996
The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study GroupE Lechler, W Schramm, C W Flosbach
Klinische Wochenschrift|May 3, 1991
High rate of false positives in blood donor screening for antibodies to hepatitis C virus. Cause of underestimation of virus transmission rate?W Prohaska, C Wolff, E Lechler, et al.
Thrombosis and Haemostasis|October 6, 1998
Thromboembolic complications associated with the use of prothrombin complex and factor IX concentratesM Köhler, P Hellstern, E Lechler, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 1, 1988
[Treatment of arterial occlusions of the lower extremities using 2-stage local application of urokinase]W Gross-Fengels, K F Neufang, E Lechler, et al.
Thrombosis and Haemostasis|October 1, 1996
Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1R Schneppenheim, U Budde, S Krey, et al.
Cancer Research|September 1, 1985
Prevalence of antibodies to HTLV-III in AIDS risk groups in West GermanyV Erfle, R Hehlmann, W Mellert, et al.
Blut|October 1, 1985
Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood productsV Erfle, R Hehlmann, W Mellert, et al.
Vox Sanguinis|January 1, 1988
Plasminogen hemizygosity. Detection of a silent allele in 7 members of a family by determination of plasminogen phenotypes, antigenic levels, and functional activityU Skoda, S F Goldmann, C Händler, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V LeidenI Pabinger, L Nemes, C Rintelen, et al.
Pageof 1